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Abstract
Clinical rationale for the study. Gilles de la Tourette syndrome (GTS) is a childhood onset disorder characterised by 
motor and vocal tics. Different types of motor tics may occur in GTS, including dystonic tics (DTs). Although DTs have 
been recognised as part of GTS symptomatology, little is known about their risk factors or about how often and at what 
age they appear in affected individuals. 
Aim of the study. The aim of our study was to investigate lifetime prevalence and clinical correlations of DTs in a Polish 
cohort of GTS patients.
Material and methods. We performed a prospective, one-registration study in a cohort of 207 consecutive ambulatory 
patients (mean age: 16.5 ± 9.4 years, 131 children, 162 males) with GTS. Duration of GTS was 9.0 ± 8.0 years (range: 
1–39 years). DTs were diagnosed during the interview. DTs were defined as slower and lasting longer than typical clonic 
tics, abnormal dystonia-like movements that led to a sustained, but not fixed, posture. 
Results. DTs occurred at some point in the lifetime of 73.9% (n = 153) of patients. The prevalence of DTs in adults and 
children was almost the same (p = 0.963). Age at onset of DTs was 9.9 ± 5.2 years with the most frequent onset in 
children (7–11 years, 74.4%, n = 64), followed by adolescence (12–18 years; 17.4%, n = 15) and adulthood (≥ 18 years, 
8.1%, n = 7). DTs occurred 3.7 ± 4.2 years after tic onset. On average, patients suffered from 1.8 ± 1.7 types of DTs. The 
most frequent manifestations of DTs were: eyes (tightening resembling blepharospasm 84.3%, n = 129 and oculogyric 
crisis 45.8%, n = 70), trunk (dystonic postures 59.5%, n = 91), jaw (bruxism 34.6%, n = 53), neck (30.7%, n = 47), upper 
limb (26.1%, n = 40), and foot (20.9%, n = 32). Multivariate logistic regression analysis showed significant associations 
of DTs with the total number of simple, and the total number of complex, tics.
Conclusions and clinical implications. DTs are early and frequent symptoms of GTS. They tend to localise in the facial 
area. DTs occur more frequently in individuals with a higher number of tics and probably add to the global impairment 
caused by tics.
Key words: Gilles de la Tourette syndrome, dystonic tics, simple tics, complex tics, dystonia
Przedrukowano za zgodą z: Neurologia i Neurochirurgia Polska 2019; 53 (5): 335–340, DOI: 10.5603/PJNNS.a2019.0046
Address for correspondence: Piotr Janik, Department of Neurology, Medical University of Warsaw, Banacha 1a Srt., 02-091 Warsaw, Poland,  
e-mail: piotr.janik@wum.edu.pl
Introduction
Gilles de la Tourette syndrome (GTS) is a childhood 
onset disorder characterised by motor and vocal tics. 
In up to 90% of patients, psychiatric comorbidities also 
occur. Different types of motor tics have been recognised 
as part of GTS symptomatology. Tics are generally brief. 
They can be categorised as clonic (less than 100 ms) or 
dystonic and tonic (more than 300 ms). Dystonic tics (DTs) 
are less common than clonic tics and are characterised 
by a repetitively abnormal posture similar to dystonia (e.g. 
torticollis). In tonic tics, there is a relatively long duration 
of contraction (in e.g. tension of abdominal muscles) but 
without exhibiting any abnormal postures.
DTs are known as a part of GTS symptomatology [1], 
but studies dedicated exclusively to DTs in GTS are scarce. 
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Two reports describing this phenomenon were published 
by Jankovic and Stone in 1991 [2] and 1994 [3]. In the 
first study, 156 GTS patients were included and 57% of 
them had DTs. The authors examined the patients not only 
clinically but in some cases, when DTs were present at the 
time of examination, they also used surface electromy-
ography (EMG). The group was divided into two subgroups 
i.e. only clonic tics, and both clonic and dystonic tics. The 
patients with DTs had more head trauma, were suffering 
more frequently from attention deficit hyperactivity disorder 
(ADHD), and had more relatives who had tics. The next study 
dedicated to DTs was published by Jankovic in 1994 and 
focused on the treatment of DTs with botulin toxin. Howe-
ver, this study included just 10 patients, five with DTs that 
involved the eyes and five involving the neck muscles. This 
study focused merely on the effectiveness of botulin toxin. 
A slightly different entity was described recently by 
Erro et al. [4]. They presented 11 patients with adult-onset 
primary DTs, which seems to be an intermediate disorder 
between tics and dystonia because it bears some charac-
teristics of tics (localisation) and some of dystonia (sensory 
gestures, progression to dystonia in one case). 
Finally, there have been two publications regarding 
co-existing tics and dystonia [5, 6]. Stone and Jankovic [5] 
described nine patients who developed dystonia additional-
ly to their vocal and motor tics. Importantly, these patients 
were not treated with neuroleptics to exclude possible 
tardive dystonia. However, the authors underlined that the 
co-existence of both diseases could be mere chance due to 
the very small sample. Twenty years later, in 2011, Damásio 
et al. [6] analysed a group of 224 patients with tics; 20 of 
them developed dystonia. The group with dystonia was 
clearly distinguished from the patients without it, and the 
authors characterised the syndrome of a primary condition 
of tics associated with persistent focal/segmental dystonia. 
The subjects with dystonia had later age of onset, lesser 
severity of tics, and lower frequency of associated featu-
res such as depression, obsessive compulsive symptoms 
(OCS) and ADHD.
Clinical rationale for the study
Although DTs have been recognised as part of GTS 
symptomatology, nonetheless little is still known about 
how often and at what age they appear in affected in-
dividuals, or if their occurrence is related to any clinical 
factors. Moreover, previous reports were only based on 
very small samples. Our study aimed to answer all of the 
above questions and confirm previous findings in a larger 
group of patients.
Material and methods
Study participants
Our cohort of GTS cases comprised 207 consecutive 
ambulatory patients aged 5–50 years (mean age: 16.5 ± 
9.4 years; 162 males). The subjects were evaluated from 
2013 to 2018. 131 children (62.6%, mean age: 10.4 ± 
3.1 years), and 76 adults (mean age: 27.2 ± 7.4 years) 
were enrolled. The mean age at tic onset was 6.4 ± 
2.7 years. Duration of GTS was 4.9 ± 3.0 years (range: 
0–13) in children and 18.3 ± 7.3 years (range: 6–39) in 
adults. 167 (80.7 %) patients had at least one psychiatric 
co-morbidity. To assess current tic severity, we used the 
Yale Global Tic Severity Scale (YGTSS) [7, 8]. The worst 
lifetime tic severity was investigated and each patient was 
asked to determine whether their peak tic severity was 
mild, moderate, or severe. The total number of tics was 
measured using the YGTSS: for each simple or complex 
vocal and motor tic, the patient received one point. The pa-
tients were evaluated for the clinical diagnosis of GTS and 
co-morbid mental disorders according to the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-IV-TR). 
We questioned in order to determine different types of 
tics experienced by patients. OCS was diagnosed if ob-
sessions and compulsions were egosyntonic, as opposed 
to egodystonic symptoms which characterise obssesive-
-compulsive disorder (OCD). The diagnosis of co-morbid 
mental disorders was also established on the basis of 
earlier psychiatric examinations that had been performed 
before the patient had been evaluated. This allowed us to 
address psychiatric disorders that are usually diagnosed 
in childhood (e.g. ADHD or oppositional defiant disorder) 
and also those for which symptoms were not yet present 
in adult patients at the time of examination. However, 
this applied only to a few subjects. We counted the total 
number of psychiatric disorders for each patient (defined 
according to DSM-IV-TR, the following disorders: ADHD, 
OCD, depression, anxiety disorder, conduct disorder, 
oppositional defiant disorder, pervasive developmental 
disorder, and learning disorder). Only the mental dise-
ases classified in DSM were added to the total number 
of psychiatric disorders. All the patients were referred to 
neurologists experienced in movement disorders and were 
personally interviewed by the author of the study (PJ). 
The study was designed as a one-time registration study, 
and no new clinical data obtained on follow-up visits was 
included in the analysis. 
The collection of clinical data from patients with GTS 
was approved by the Ethics Committee of the Medical 
University of Warsaw (KB/2/2007).  
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Definition and differentiation of DTs
DTs were defined as sustained contractions of muscles 
that led to abnormal, short-lasting, unfixed postures. We 
explained to the patients the differences between jerk-like 
movements (clonic tics) and slower and sustained DTs to 
facilitate the differentiation between those two movements. 
DTs were mainly differentiated into clonic tics, dystonia 
and tonic tics. As described by Jankovic [9], clonic tics are 
brief and jerk-like, involve only a single muscle or a group 
of muscles, and last less than 100 ms. Tonic tics consist of 
isometric muscle tension, which is typically brief tension of 
abdominal or limb muscles that lasts more than 300 ms. 
Finally, dystonia is abnormal posturing that ends in fixation, 
cannot be controlled voluntarily, and sometimes resolves 
after some gestures (gestes antagonistes). Patients and/or 
their caregivers were asked by the interviewer whether 
they had experienced such symptoms in the past or were 
experiencing them currently. We defined DTs as a current 
symptom when it had been present during the previous 
seven days, analogically to tic evaluation according to the 
YGTSS. In some cases, DTs were also witnessed at the time 
of examination or the diagnosis was supported by a video 
recording that had been provided by the subject or her/his 
family, or was recorded during the clinical evaluation. We 
additionally collected information about the anatomical 
region affected by DTs, and showed the patients examples 
of characteristic movements localised in each region (e.g. 
strong contraction of eyelid muscles resembling blepharo-
spasm, slow head turning toward the arm similar to torticol-
lis). As indicated by Ella et al. [10] and following Jankovic 
and Stone [2], we used the term ‘bruxism’ to describe DTs 
involving the mandibular region. 
Statistical analysis
The statistical analyses were performed using STATI-
STICA ver 13.1 and SPSS ver 25 software. Normality of 
distribution was assessed using the Shapiro-Wilk test. For 
parametric variables, data was presented as arithmetic 
means and standard deviations (mean ± SD). For non-
-parametric variables, data was presented as median and 
quartiles (25; 75). Categorical variables were presented 
as frequencies (percentages). The parametric data was 
compared by an independent t-test and the nonparametric 
data by the Mann-Whitney U-test, as appropriate, and the 
categorical data was compared by the Fisher’s exact test 
(two-sided).
In both analyses, comparisons between groups were 
considered significantly different when a two-tailed test was 
p < 0.05. All variables that were significant in the primary 
analyses were entered into a logistic regression analysis in 
order to determine risk factors for DTs in GTS patients. In 
addition, gender and age were entered into the multivariate 
model as control variables.
Results
DTs occurred at some point in the lifetime of 73.9% 
(n = 153) of patients, in 57 adults and 96 children. In 41.2% 
of patients (n = 63), DTs had only been present in the past 
and not at the time of evaluation. The prevalence of DTs in 
adults and children was almost the same (p = 0.963, 75%, 
n = 57 vs. 73.2%, n = 96, respectively). Age at onset of DTs 
was known only in 57% (n = 86) of patients, with the most 
frequent onset in children (7–11 years, 74.4%, n = 64), 
followed by adolescence (12–18 years; 17.4%, n = 15) 
and adulthood (≥ 18 years, 8.1%, n = 7). The age of onset 
was known in 23 adults (23/57, 40.4%) and in 63 children 
(63/96, 65.6%). Mean age of DTs onset was 9.9 ± 5.2 years 
compared to 6.4 ± 2.8 years for GTS onset. On average, 
patients suffered from 1.8 ± 1.7 types of DTs. The most 
frequent localisations of DTs were: eyes (tightening resem-
bling blepharospasm 84.3%, n = 129 and oculogyric crisis 
45.8%, n = 70), trunk (dystonic postures 59.5%, n = 91), 
jaw (bruxism 34.6%, n = 53), neck (30.7%, n = 47), upper 
limb (26.1%, n = 40), and foot (20.9%, n = 32). 
In univariate analyses, patients with DTs suffered from 
more severe tics, had more simple and complex tics, and 
more psychiatric comorbidities (ADHD, OCD, depression, 
anxiety disorder, conduct disorder, pervasive developmen-
tal disorder, oppositional defiant disorder, and learning 
disorder). Multivariate logistic regression analysis showed 
only significant associations of DTs with total number of 
simple and total number of complex tics. The results of 
univariate und multivariate analysis are shown in Table 1. 
Discussion
Our study is one of the very few to have reported about 
DTs in GTS. Previous reports date back to the 1990s and 
include smaller study samples. In our sample, DTs were 
found in the majority of patients (73.9%), they started 
mainly in childhood and adolescence, were located in the 
face, and correlated with the total number of tics. 
In the publication by Jankovic and Stone from 1991 [2], 
the prevalence of DTs was lower than in our group. This co-
uld be related to a different methodology. Jankovic and Sto-
ne used additionally EMG in some cases to determine the 
exact duration of the tic. Clonic tics last less than 100 ms 
while dystonic last more than 300 ms. However, they used 
this measurement only in some patients and did not report 
whether the amount of patients with DTs had changed after 
using surface EMG. We can only suspect that the amount of 
patients categorised as DTs+ in our sample could be liable 
to change if one were to apply surface EMG. Moreover, 
Jankovic and Stone used DSM III criteria to diagnose GTS 
and their sample was smaller than ours (156 vs. 207). In 
the study by Jankovic and Stone the patients with DTs had 
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more ADHD and head trauma. In our sample, univariate 
analysis showed that patients with DTs were more affected 
by tics as well as having more psychiatric comorbidities, 
but multivariate regression confirmed only a relationship 
with the number of motor and vocal tics. 
The age at onset was known in only 57% of patients. 
Unsurprisingly, it was better known in children (65.6%) 
than in adults (40.4%). This could be related to the fact 
that usually DTs start in childhood or adolescence and that 
therefore some adults could not recall when DTs had star-
ted due to the long interval between the onset of DTs and 
the clinical evaluation. Additionally, in children with DTs, 
the medical history was always supported by information 
given by at least one parent. 
Although we did not use objective measurements to 
assess impairment due to tics, we believe that DTs may 
add to global impairment, which was confirmed by correla-
ting with the YGTSS. We speculate that also a correlation 
between the total number of tics and lifetime peak tic 
severity indicates that such patients have more tics and, 
in consequence, this can also aggravate global impairment 
in some patients. Nevertheless, patients with DTs did not 
receive more frequently medication for tics. 
Similarly to other studies, also in our group, DTs tended 
to localise in the head and neck area. This localisation 
is also typical for clonic tics. Interestingly, in a group of 
patients with co-existing dystonia and tics described by 
Damásio et al., the most frequent was cervical dystonia [6]. 
DTs must be differentiated from primary dystonia. The 
main difference is that while DTs are characterised by 
a temporarily sustained posture, in dystonia the abnormal 
posturing is fixed. Also, the dystonia is constant, with a fixed 
Table 1. Characteristics and associations of DTs
General comparison between DTs+ and DTs- groups
Variable
GTS patients 
(n = 203)
Patients with DTs 
(n = 153)
Patients without DTs 
(n = 54) p
Age at evaluation [years] 
[median] (IQR) 14 (9–22) 11 (9–23) 0.60
Gender (male/female) 124/29 38/16 0.102
YGTSS [median] (IQR) 50 (31–65) 35 (21–49) 0.0004
Total number of simple tics [mean ± SD] 13.73 ± 4.76 9.36 ± 3.92 0.000
Total number of complex tics [median] (IQR) 8 (5–13) 3 (1–6) 0.000
Number of mental disorders [median] (IQR) 2 (1–3) 1 (0–2) 0.002
Medication for tics [at evaluation] n = 67 (43.8%) n = 21 (38.9%) 0.531
Peak tic severity [median] (IQR) 2 (2–3) 2 (1–2) 0.000
Family history of tics or GTS n = 35 (22.9%) n = 13 (24.1%) 0.934
Family history of OCD or OCS n = 52 (34.0%) n = 15 (27.8%) 0.276
Logistic regression model
Multivariate 
Analysis
Variable OR (95% CI) p
Age 1.019 (0.972–1.068) 0.429
Gender 0.755 (0.315–1.813) 0.529
Peak tic severity 1.509 (0.716–3.180) 0.279
YGTSS 0.974 (0.907–1.046) 0.472
Total number of simple tics 1.174 (1.042–1.323) 0.008
Total number of complex tics 1.248 (1.082–1.440) 0.002
Number of mental disorders 0.854 (0.629–1.160) 0.312
n — number of patients; IQR — interquartile range; SD — standard deviation; OR — odds ratio; CI — confidence interval; DTs — dystonic tics; GTS — Gilles de la Tourette Syndrome; YGTSS — Yale Global Tic 
Severity Scale; OCD — obsessive-compulsive disorder; OCS — obsessive-compulsive symptoms; p — DTs+ vs. DTs-; p value < 0.05 are shown in bold. For non-parametric variables, data is presented as median 
and interquartile range. Categorical variables are presented as frequencies (percentages)
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pattern of movement, while DTs wax and wane in intensity 
and localisation, as do all tics in GTS. Helpful clues based on 
clinical observations that could help to differentiate DTs from 
dystonia are summarised in Table 2. 
None of the patients in our sample had a history 
of dystonia. Nevertheless, Damásio et al. [6] detected 
20 cases of dystonia (8.9%) in his sample of 224 patients 
with tics. The group of patients included in this study was 
very heterogenous, some of the patients had tic onset in 
childhood, some in adulthood, plus patients with GTS but 
also chronic tic disorder were enrolled. This could possibly 
bias the results. Previously, Stone and Jankovic [5] presen-
ted nine cases (5%) of GTS and dystonia. It seems to be, 
therefore, a quite rare phenomenon, but one that should 
be taken into consideration. Nevertheless, the authors 
mention that those numbers could be biased as only seve-
rely affected patients are treated in Movement Disorders 
Centers, where their study was conducted. 
The second disorder that can resemble DTs is tardive 
dyskinesia, especially tardive dystonia. Tardive dyskinesia 
is a disorder characterised by involuntary movements, ty-
pically of the orofacial muscles and also of the extremities 
and other muscle groups. The condition is associated with 
exposure to dopamine receptor blocking agents, including 
antipsychotics that are commonly used in the treatment 
of tics. Among psychiatric patients, the risk of developing 
tardive dyskinesia is quite high, especially when treated with 
first generation antipsychotics and when this treatment is 
long-lasting. Correll et al. reported the annual prevalence 
of tardive dyskinesia as being as high as 3.9% for first 
generation antipsychotics and 5.5% for second generation 
antipsychotics [11]. Müller-Vahl and Krüger [12] analysed 
records of 521 GTS patients treated with neuroleptics. None 
of them developed tardive dyskinesia, but most patients 
were treated with neuroleptics for less than a year. Although 
tardive dyskinesia seems to be a quite rare side effect in 
GTS, it should be considered. To distinguish tardive dystonia 
from DTs we should consider the exposure to neuroleptics. 
Tardive dystonia usually persists for longer, even after di-
scontinuation of the offending drug. DTs are tics, so their 
intensity changes, and they can even disappear suddenly. 
DTs are not permanent, but there are periods of remission 
and relapse. Furthermore, slow tapering should improve, 
while sudden dose reduction may aggravate, drug-induced 
dystonia. 
The next type of tics that should be taken into consi-
deration in a differential diagnosis of DTs are tonic tics. 
Similarly to DTs, tonic tics are slow, but they do not lead 
to sustained posturing. Typical tonic tics are located in the 
abdominal or limb muscles. It is often unclear whether 
the subject is suffering from DTs or tonic tics, and it is 
crucial to explain the difference to the patient. However, 
we did not find any correlation between DTs and tonic 
tics (p = 0.103). 
Finally, Erro et al. [4] suggested that patients who 
develop DTs during adulthood represent a totally different 
group which they named adult-onset primary dystonic tics. 
From their database of 253, they found 21 with DTs and 
10 of them developed DTs after the age of 18 as the first 
manifestation of an unspecified tic disorder. Some of those 
movements were evaluated posteriorly to dystonia, so the 
authors suggested that adult onset primary dystonic tics 
represent a transient entity between tics and dystonia. In 
our sample, only seven patients had DTs onset in adulthood 
(7/153, 4.6%). To the best of our knowledge, none of them 
developed dystonia or had other features that resembled 
dystonia such as geste antagoniste. 
Clinical implications/future directions 
DTs are frequent and early symptoms in GTS and should 
be considered by clinicians. Therefore, we believe that our 
study has an important clinical value. DTs normally appear 
in the facial region. DTs occur in patients who have more 
tics and they probably aggravate the impairment caused 
by tics. They should be differentiated from primary focal/ 
/segmental dystonia, tonic tics and tardive dystonia. We 
should therefore take into account that patients with DTs 
may require more clinical attention due to greater impair-
ment. As indicated by Jankovic [3], botulin toxin could also 
be used in the treatment of DTs. 
Limitations
The biggest limitation of our study is the recall bias. 
Many adult patients did not remember the presence or the 
age of onset of DTs in their childhood, and only in some 
cases was it possible to obtain this additional information 
from a family member. We also did not use superficial EMG 
to make the assessment more objective. Another objective 
method, video recording, was available only in some cases 
Table 2. Distinguishing features between dystonic tics and dysto-
nia
Parameter DTs Dystonia 
Male predominance + –
Co-occurrence of phonic and clonic tics + –
Suppressibility + –
Growing inner tension during suppression + –
Premonitory urge + –
Waxing and waning course + –
Amelioration in adulthood + –
Geste antagoniste – +
Fixed posture – +
Unchanged pattern – +
DTs — dystonic tics
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in our study. The design of our one-time registration study 
may have also inﬂuenced the prevalence of DTs. Moreover, 
we used different methods of data collection from children 
as opposed to adults. Most clinical information regarding 
children was provided by their parents, whereas adults 
reported themselves. 
Funding: This publication was prepared without any 
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